Insider Trading & Ownership - Call Matthew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Call Matthew

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-07
Option Award
2024-03-08
8:00 pm
N/A
2034-03-07
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
225,000$0225,000
(Direct)
View
2023-12-05
Option Award
2023-12-07
8:22 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
44,000$0137,898
(Direct)
View
2023-03-28
Exercise
2023-03-29
8:00 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
40,226$2.95201,762
(Direct)
View
2023-03-28
Exercise
2023-03-29
8:00 pm
N/A
2029-12-04
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
40,226$0201,762
(Direct)
View
2023-03-09
Option Award
2023-03-10
7:52 pm
N/A
2033-03-09
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
130,000$0130,000
(Direct)
View
2022-03-11
Option Award
2022-03-14
7:58 pm
N/A
2032-03-11
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
85,000$085,000
(Direct)
View
2021-07-30
Exercise
2021-08-05
7:55 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
53,672$2.95201,762
(Direct)
View
2021-07-30
Exercise
2021-08-05
7:55 pm
N/A
2029-12-04
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
53,672$0201,762
(Direct)
View
2021-06-24
Option Award
2021-06-25
8:00 pm
N/A
2031-06-24
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
72,000$072,000
(Direct)
View
2021-03-01
Option Award
2021-03-03
4:15 pm
N/A
2031-03-01
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
72,000$072,000
(Direct)
View

Ownership
2020-07-23
7:21 pm
N/A
2029-12-04
iTeos Therapeutics Inc.ITOSCall Matthew
Chief Operating Officer
0$0365,671
(Direct)
View